National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2019-23282"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2019-23282"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2019-10-25"
last_updated: "2019-10-25"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2019-23282"
document_type: "notice"
publication_date: "2019-10-25"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "84 FR 57455"
fr_volume: 84
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the Board of Scientific Counselors for Clinical Sciences and Epidemiology National Cancer Institute, November 4, 2019, 9:00 a.m. to 3:45 p.m., National Institutes of Health, Building 45, Natcher Building, Conference Room D, 45 Center Drive, Bethesda, MD 20892, which was published in the *Federal Register* on February 15, 2019, 84 FR 4487.

This meeting notice is amended to add an open session from 9:05 a.m. to 9:35 a.m. to present Remarks from the Acting Director, NCI and to change the meeting end time from 3:45 p.m. to 5:00 p.m. The meeting is partially closed to the public.

Dated: October 21, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.